- Home
- ACCO vs CADL Comparison
ACCO vs CADL Comparison
Compare ACCO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- CADL
- Stock Information
- Founded
- ACCO 1893
- CADL 1999
- Country
- ACCO United States
- CADL United States
- Employees
- ACCO N/A
- CADL 38
- Industry
- ACCO Publishing
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- CADL Health Care
- Exchange
- ACCO Nasdaq
- CADL Nasdaq
- Market Cap
- ACCO 311.7M
- CADL 315.1M
- IPO Year
- ACCO N/A
- CADL 2021
- Fundamental
- Price
- ACCO $3.52
- CADL $6.27
- Analyst Decision
- ACCO Buy
- CADL Strong Buy
- Analyst Count
- ACCO 1
- CADL 5
- Target Price
- ACCO $6.00
- CADL $21.40
- AVG Volume (30 Days)
- ACCO 547.1K
- CADL 996.0K
- Earning Date
- ACCO 07-31-2025
- CADL 08-12-2025
- Dividend Yield
- ACCO 8.55%
- CADL N/A
- EPS Growth
- ACCO N/A
- CADL N/A
- EPS
- ACCO 0.49
- CADL N/A
- Revenue
- ACCO $1,581,200,000.00
- CADL N/A
- Revenue This Year
- ACCO N/A
- CADL N/A
- Revenue Next Year
- ACCO $0.58
- CADL N/A
- P/E Ratio
- ACCO $7.17
- CADL N/A
- Revenue Growth
- ACCO N/A
- CADL N/A
- 52 Week Low
- ACCO $3.32
- CADL $3.79
- 52 Week High
- ACCO $6.44
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ACCO 38.26
- CADL 51.81
- Support Level
- ACCO $3.40
- CADL $6.11
- Resistance Level
- ACCO $3.84
- CADL $6.40
- Average True Range (ATR)
- ACCO 0.13
- CADL 0.35
- MACD
- ACCO -0.05
- CADL -0.09
- Stochastic Oscillator
- ACCO 14.62
- CADL 17.54
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.